Drugs / 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01035437 | Dec 2009 → Jan 2011 | neoplasm of esophagus | Roswell Park Cancer Institute | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a) | “HPPH 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a)” NCT01035437 ↗ |
| Known as | HPPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01035437 ↗ |